Table 10.

Association between NLRP3 haplotypes and tradition treatment for AS

Haplotype	ASAS20effects/total	AOR (95% CI)	P value
C‐A‐C‐C	34/51	Ref	‐
C‐A‐C‐T	12/18	0.911 (0.287‐2.890)	.874
C‐A‐T‐C	8/14	0.601 (0.176‐2.047)	.415
C‐A‐T‐T	1/3	0.215 (0.018‐2.632)	.229
C‐G‐C‐C	9/12/	1.394 (0.330‐5.896)	.652
C‐G‐C‐T	5/6	2.445 (0.259‐23.056)	.435
C‐G‐T‐C	1/1	‐	1
C‐G‐T‐T	1/2	0.521 (0.030‐8.993)	.653
T‐A‐C‐C	10/19	0.537 (0.182‐1.585)	.26
T‐A‐C‐T	12/16	1.437 (0.400‐5.161)	.578
T‐A‐T‐C	7/10	1.109 (0.252‐4.874)	.891
T‐A‐T‐T	5/7	1.054 (0.179‐6.213)	.953
T‐G‐C‐C	10/16	0.819 (0.253‐2.649)	.739
T‐G‐C‐T	12/16	1.485 (0.414‐5.325)	.544
T‐G‐T‐C	1/5	0.103 (0.010‐1.034)	.053
T‐G‐T‐T	2/4	0.523 (0.067‐4.069)	.536

AS, ankylosing spondylitis; Ref, Reference level; AOR, adjusted odds ratio after age and gender correction; CI, confidence interval; P value.